
According to a new market research report " Immunotherapy Drugs system Market by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", published by MarketDataForecast™, the Immunotherapy Drugs market is expected to reach USD 112.69 Billion by 2021 from USD 68.4 Billion in 2016, at a CAGR of 10.5%. Factors driving the growth of this market include rising disease incidences, reduction in time of drug development, and higher efficient with low side effects caused from immunotherapy.